Evidence map›Paper›PMID 42598122›Full record

ReviewAJPM focus2026

HIV Pre-Exposure Prophylaxis Care Continuum in Outpatient Settings: A Systematic Review and Meta-Analysis.

Ashley A Stultz, Shao-Hsuan Chang, Debbie L Wilson, Pilar Hernandez-Con, Amanda Joseph, Ikenna F Unigwe, Hsin-Yueh Lin, Julia Yang, Lauren E Adkins, Robert L Cook and 3 more

Abstract readReview
In one paragraph

Review in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ashley A StultzDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Shao-Hsuan ChangDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Debbie L WilsonDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Pilar Hernandez-ConDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Amanda JosephDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Ikenna F UnigweDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Hsin-Yueh LinDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Julia YangDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.
Lauren E AdkinsHealth Science Center Libraries, University of Florida, Gainesville, Florida.
Robert L CookDepartment of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida.
Jennifer W JanelleDepartment of Medicine, College of Medicine, University of Florida, Gainesville, Florida.
Danielle S NelsonDepartment of Community Health and Family Medicine, College of Medicine, University of Florida, Gainesville, Florida.
Haesuk ParkDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida.

Funding

Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable PopulationsK01DA045618 · NIDA · UNIVERSITY OF FLORIDA · PI PARK, HAESUK · 2018 to 2022
$648k
NCATS NIH HHS UL1 TR001427NIDA NIH HHS K01 DA045618
6 · The paper itself

Abstract

Introduction: Pre-exposure prophylaxis is a prescription medication that prevents HIV infection and transmission in those at risk for HIV infection. The authors examined engagement in the oral pre-exposure prophylaxis care continuum among HIV-negative individuals at risk for HIV in outpatient settings in the U.S. after participation in a pre-exposure prophylaxis-related intervention, to identify key gaps in the continuum where current interventions are least effective. Methods: This systematic review and meta-analysis included U.S. studies published from January 2012 through August 2022, reporting at least 2 of 7 pre-exposure prophylaxis care continuum steps from the identification of HIV-negative, at-risk pre-exposure prophylaxis-eligible persons to pre-exposure prophylaxis initiation. The final 2 steps-pre-exposure prophylaxis adherence and retention-of the continuum's 9 steps were not analyzed owing to the substantial heterogeneity in how the included studies measured these steps and the limited sample sizes across the studies. Random-effects meta-analyses, which describe the distribution of effects across studies, were performed to estimate pooled proportions of each step, and subgroup analyses were conducted on the basis of population characteristics (e.g., individuals with a sexually transmitted infection, men who have sex with men) and study settings (i.e., emergency department, ambulatory care, healthcare system, and other). Results: The authors included 2,510 articles in title and abstract review, 296 were retrieved for full-text review, and 34 studies met the inclusion criteria and were included in the meta-analysis. The 34 studies were comprised of 71,162 individuals eligible for pre-exposure prophylaxis. Among them, 66% had increased HIV risk awareness, 55% had enhanced pre-exposure prophylaxis awareness, 49% had facilitated pre-exposure prophylaxis access, 42% were linked to pre-exposure prophylaxis care, 40% were prescribed pre-exposure prophylaxis, and 34% initiated pre-exposure prophylaxis use. Subgroup analysis indicated that individuals identified in emergency department settings and those with sexually transmitted infections had lower pre-exposure prophylaxis initiation rates than those identified in all other settings and men who have sex with men, respectively. Discussion: There was a progressive decline in the proportion of individuals engaged in the pre-exposure prophylaxis care continuum. These findings suggest that comprehensive efforts are needed across all settings to increase perceived susceptibility to HIV among high-risk individuals and to capitalize on the opportunity of sexually transmitted infections care and emergency department visits to engage patients in the pre-exposure prophylaxis care continuum.

Indexed as

care continuumHIVinterventionLinkage to careoutpatient settingpre-exposure prophylaxis

Identifiers

PMID42598122
PMCPMC13471208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.